Rheumatology
Service
Inmaculada
Ros Vilamajó
Publications by the researcher in collaboration with Inmaculada Ros Vilamajó (10)
2024
-
Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry
Arthritis Research and Therapy, Vol. 26, Núm. 1
-
Real-world apremilast use in biologic-naïve psoriatic arthritis patients. Data from Spanish clinical practice
Reumatologia Clinica, Vol. 20, Núm. 1, pp. 24-31
2023
-
Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)
Seminars in Arthritis and Rheumatism, Vol. 58
-
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
RMD open, Vol. 9, Núm. 1
-
Long-term retention of golimumab treatment in clinical practice in a large cohort of patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis
Musculoskeletal Care, Vol. 21, Núm. 1, pp. 189-197
2021
-
Changes in the use patterns of bDMARDs in patients with rheumatic diseases over the past 13 years
Scientific Reports, Vol. 11, Núm. 1
2020
-
Influence of age on the occurrence of adverse events in rheumatic patients at the onset of biological treatment: Data from the BIOBADASER III register
Arthritis Research and Therapy, Vol. 22, Núm. 1
2017
-
Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort
Arthritis Care and Research, Vol. 69, Núm. 6, pp. 938-942
-
Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis
Arthritis Care and Research, Vol. 69, Núm. 1, pp. 150-155
2016
-
Differences between familial and sporadic early spondyloarthritis: Results from the ESPERANZA cohort
Clinical and Experimental Rheumatology, Vol. 34, Núm. 4, pp. 575-580